发明名称 |
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same |
摘要 |
The present invention relates unit dose formulations of antidotes to anticoagulants targeting factor Xa. Disclosed herein are methods of stopping or preventing bleeding in a patient that is currently undergoing anticoagulant therapy with a factor Xa inhibitor. |
申请公布号 |
US9056106(B2) |
申请公布日期 |
2015.06.16 |
申请号 |
US201012836536 |
申请日期 |
2010.07.14 |
申请人 |
Portola Pharmaceuticals, Inc. |
发明人 |
Sinha Uma;Lu Genmin;Hutchaleelaha Athiwat;Hollenbach Stanley J. |
分类号 |
A61K38/48;C12N9/64 |
主分类号 |
A61K38/48 |
代理机构 |
Sheppard Mullin Richter & Hampton LLP |
代理人 |
Sheppard Mullin Richter & Hampton LLP |
主权项 |
1. A unit dose formulation consisting essentially of a pharmaceutically acceptable carrier and from about 200 milligrams to about 1 gram of a two-chain polypeptide comprising the amino acid sequence of SEQ ID NO. 13. |
地址 |
South San Francisco CA US |